LDHA and central nervous system cancer: Specific deletion of promoter methylation of glycolytic genes, particularly lactate dehydrogenase A (LDHA), results in the acquisition of a hyperglycolytic phenotype [54], leading to lactate accumulation that correlates with the grade of glioma, enhanced proliferative invasiveness, and poorer survival [36,55,56].